DuPont purchases enzyme assets from Dyadic

On December 31, 2015 Dyadic announced the closing of the sale of substantially all of the assets of its Industrial Technology business to DuPont’s Industrial Biosciences business, including Dyadic’s C1 platform.

Learn More

BiofuelsBiochemicalsBiopharmaceuticalsAnimal FeedPulp and PaperTextilesFood and BeverageNutraceuticals

Welcome to Dyadic. We are a global biotechnology company with patented and proprietary technologies that are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic’s C1 platform technology enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. Dyadic leverages the value of its technologies through licensing arrangements and other collaborations with third parties who receive the benefits of producing and using the proteins these technologies help produce. LEARN MORE

Recent News

April 28, 2016
Dyadic to Announce 1Q2016 Financial Results and Host Conference Call
Click Here

April 6, 2016
Dyadic Announces Settlement with One of Two Remaining Law Firms
Click Here

March 29, 2016
Dyadic Reports 2015 Annual Financial Results
Click Here

March 3, 2016
Dyadic Announces Court Trial Date
Click Here

December 31, 2015
Dyadic Announces Closing of Sale of Industrial Technology Business
Click Here

Upcoming Events

Mark Emalfarb presents and is available for one-on-one meetings at:
Pioneers 2016
Presented by Joseph Gunnar & Co., LLC

May 5, 2016 New York Palace Hotel, New York City
Presentation time slot: 9:30am ET on Thursday, May 5th in Hubbard 1 on the Fifth Floor of the Palace
Click Here

Mark Emalfarb presents at:
Marcum Microcap Conference
June 1 and 2, 2016 The Grand Hyatt Hotel, New York City
Click Here

Mark Emalfarb attends:
BIO International Convention
June 6 - 9, 2016 Moscone Center, San Francisco, CA
Click Here


SNNLive Interview with Mark Emalfarb, CEO and Founder, Dyadic International, Inc
October 2015

Mark Emalfarb Presentation at 2015 BIO World Congress in Montreal
July 19-22, 2015

Mark Emalfarb Interview at LD Micro VI
Los Angeles, December 3-5, 2013